GlassScriptPhysician profile
Stacey Krasnoff
NPI 1700436136
$3,824.89
in general payments reported to CMS, 2019-2025
31 companies · $2,212 in 2025
The $2,212 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $33.17 · 2022: $108 · 2023: $685 · 2024: $786 · 2025: $2,212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,683.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $879.59 | 2022-2025 | Farxiga, Breztri |
| Glaxosmithkline, LLC. | $425.17 | 2022-2025 | Trelegy Ellipta |
| Indivior INC. | $380.82 | 2023-2025 | Sublocade |
| Novo Nordisk INC | $257.76 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $254.68 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $176.56 | 2024-2025 | Trintellix, Glassia |
| Idorsia Pharmaceuticals US INC | $169.29 | 2022-2023 | Quviviq |
| Otsuka America Pharmaceutical, INC. | $163.43 | 2024-2025 | Rexulti, Jynarque, Nuedexta |
| Lilly USA, LLC | $146.33 | 2025 | Mounjaro, Zepbound, Jardiance |
| Lundbeck LLC | $140.51 | 2025 | Rexulti |
| Amneal Pharmaceuticals LLC | $68.60 | 2024-2025 | Unithroid |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $65.33 | 2023-2025 | Xifaxan |
| Merck Sharp & Dohme LLC | $61.53 | 2021-2025 | Capvaxive, Lagevrio, Verquvo |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $59.88 | 2025 | Caplyta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.19 | 2022-2025 | Jardiance |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $56.31 | 2025 | Vivitrol |
| Bayer Healthcare Pharmaceuticals INC. | $51.95 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $49.18 | 2025 | |
| Amgen INC. | $44.77 | 2025 | Otezla, Repatha |
| Pfizer INC. | $36.69 | 2023-2024 | |
| Uswm, LLC | $34.46 | 2023 | Zimhi, Lucemyra |
| Paratek Pharmaceuticals, INC. | $31.20 | 2024-2025 | Nuzyra |
| Phathom Pharmaceuticals, INC. | $31.10 | 2024 | Voquezna |
| Astellas Pharma US INC | $30.30 | 2025 | Veozah |
| Exact Sciences Corporation | $25.67 | 2025 | The Cologuard Plus Collection Kit |
| Xeris Pharmaceuticals, INC. | $24.69 | 2025 | Gvoke Hypopen |
| Axsome Therapeutics, INC. | $23.37 | 2025 | Auvelity |
| Acella Pharmaceuticals, LLC | $23.19 | 2025 | NP Thyroid 60 |
| Echosens North America, INC. | $18.71 | 2025 | Fibroscan |
| Intra-Sana Laboratories | $18.65 | 2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Dexcom, INC. | $16.98 | 2025 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Krasnoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.